Recent APAC MRDR presentations!
The APAC MRDR Coordinating Principal Investigator, Professor Andrew Spencer, recently presented an oral presentation at Blood 2025, titled Regional trends…
Milestone Achieved: APAC MRDR Reaches 3,000 participants with Hospital Support
The APAC MRDR has recently enrolled its 3,000th patient, marking a step towards improving understanding and treatment of myeloma across…
APAC MRDR Open Meeting 2025
APAC MRDR was pleased to host the annual Open Meeting 2025 in August! The virtual meeting was a great opportunity…
Two Recent APAC MRDR Abstract Presentations!
Congratulations to A/Prof Jihyun Lee for her recent oral presentation titled “Toxicity-related treatment cessation in newly diagnosed multiple myeloma –…
APAC MRDR reaches 2,500 patients!
The APAC MRDR has enrolled our 2,500th patient in January 2025! Congratulations and thank you to all our hard working…
APAC MRDR Annual Open Meeting 2024
APAC MRDR was pleased to host the annual Open Meeting 2024 in November! This virtual event was a great opportunity…
2,200 patients registered!
The APAC MRDR has enrolled our 2,200th patient! Congratulations and thank you to all our hard working study coordinators, data…
RENJI HOSPITAL BEGINS PATIENT RECRUITMENT
Our second site in China has now begun patient recruitment. Congratulations to the team at Renji Hospital! All patients diagnosed…
APAC MRDR Methodology Paper Published
Our paper, The establishment of a multiple myeloma clinical registry in the Asia-Pacific region: The Asia-Pacific Myeloma and Related Diseases…
1,700 Patients Registered!
Congratulations to all participating APAC MRDR sites for enrolling our 1,700th patient! Thank you to all the hardworking Study Coordinators…
